NCT04800120View on ClinicalTrials.gov

Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Covid19
Interventions
OTHER

Hyperbaric Oxygen Therapy

Delivery of 100% oxygen within a hyperbaric oxygen therapy chamber

Trial Locations (1)

02780

Morton Hospital, Taunton

All Listed Sponsors
lead

Steward St. Elizabeth's Medical Center of Boston, Inc.

OTHER

NCT04800120 - Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress | Biotech Hunter | Biotech Hunter